EX-99.2 3 darkpulse_ex9902.htm PRO FORMA FINANCIAL INFORMATION

Exhibit 99.2

 

 

UNAUDITED PRO FORMA FINANCIAL STATEMENTS OF DARKPULSE INC.

 

References to “DarkPulse”, the “Company”, “we”, “us” and “our” mean DarkPulse, Inc. and its consolidated subsidiaries, unless the context otherwise requires.

 

On August 9, 2021, DarkPulse, Inc. (the “Company”) entered into a Share Purchase Agreement (the “SPA”), with Optilan Guernsey Limited and Optilan Holdco 2 Limited (the “Sellers”), pursuant to which the Company purchased from the Sellers all of the issued and outstanding equity interests of Optilan HoldCo 3 Limited, a private company incorporated in England and Wales (“Optilan”) for £1.00 and also a commitment to enter into the Subscription (as defined below). As of August 9, 2021, the Company owns all of the equity interests of Optilan.

 

The following unaudited pro forma condensed combined financial statements, which are referred to as the unaudited pro forma financial statements, have been prepared to assist in the analysis of financial effects of the SPA. The unaudited pro forma combined condensed statements of operations, which are referred to as the unaudited pro forma statements of operations, combine the historical consolidated statements of operations of DarkPulse and Optilan, giving effect to the SPA, as if it had been completed on the first day of the period. The unaudited pro forma condensed combined statements of operations for the six months ended June 30, 2021 and for the year ended December 31, 2020 were derived from the condensed consolidated financial statements of DarkPulse for the six months ended June 30, 2021 and for the year ended December 31, 2020, and the condensed financial statements of Optilan for the six months ended June 30, 2021 and for the year ended December 31, 2020. The unaudited pro forma condensed combined balance sheet, which is known as the unaudited pro forma balance sheet, combines the historical balance sheets of DarkPulse and Optilan as of June 30, 2021 and December 31, 2020, giving effect to the SPA, as if it had been completed on the first day of the period presented. The historical financial statements of Optilan have been adjusted to reflect certain reclassification and other conforming adjustments in order to align to DarkPulse condensed financial statement presentation.

 

Assumptions and estimates underlying the adjustments to the unaudited pro forma financial statements, which are referred to as the pro forma adjustments, are described in the accompanying notes. The historical consolidated financial statements have been adjusted in the unaudited pro forma financial statements to give effect to pro forma events that are directly attributable to the SPA. The unaudited pro forma financial statements have been presented for illustrative purposes only and are not necessarily indicative of the operating results and financial position that would have been achieved had the SPA and other transactions occurred on the dates indicated. Further, the unaudited pro forma financial statements do not purport to project the future operating results or financial position of the combined company following the SPA. The unaudited pro forma financial statements include the assets and liabilities of Optilan adjusted for DarkPulse’s historical cost basis. The final purchase price allocation may be materially different than that reflected in the pro forma purchase price allocation presented herein.

 

The unaudited pro forma financial statements, although helpful in illustrating the financial characteristics of the combined company under one set of assumptions, do not reflect the benefits of expected synergies or cost savings (or associated synergies or costs to achieve such savings), opportunities to earn additional revenue, or other factors that may result as a consequence of the SPA and, accordingly, do not attempt to predict or suggest future results. Further, the unaudited pro forma financial statements do not reflect (i) any other acquisition subsequent to the balance sheet date presented or (ii) the effect of any regulatory actions that may impact the results of the combined partnership following the SPA.

 

The unaudited pro forma financial statements have been developed from and should be read in conjunction with:

 

·the accompanying notes to the unaudited pro forma financial statements;

 

·the historical consolidated financial statements of DarkPulse for the six months ended June 30, 2021 and for the year ended December 31, 2020 filed as a part of the registration of which this prospectus forms a part; and

 

·the historical financial statements of Optilan for the six months ended June 30, 2021 and for the year ended December 31, 2020 filed as an exhibit to the registration statement.

 

 

 

 

 1 

 

 

DARKPULSE INC AND SUBSIDIARIES

PRO FORMA CONSOLIDATED BALANCE SHEETS

June 30, 2021

(Unaudited)

 

    DARKPULSE     Optilan              
    As Reported     Holdco 3 Limited     Pro Forma     Consolidated  
    (6/30/21)     (6/30/21)     Adjustments     Balance  
ASSETS                                
                                 
Current Assets                                
Cash   $ 148,562     $ 995,449     $     $ 1,144,011  
Other Current Assets     4,000       7,215,282             7,219,282  
Total Current Assets     152,562       8,210,731             8,363,293  
                                 
Goodwill                 6,917,687       6,917,687  
Intangible assets                 4,033,638       4,033,638  
Patents net     368,476             –        368,476  
Other Long Term Assets     179,328       2,055,789             2,235,117  
Total Assets   $ 700,366     $ 10,266,520     $ 10,951,325     $ 21,918,211  
                                 
LIABILITIES AND STOCKHOLDERS' EQUITY                                
                                 
Current Liabilities                                
Accounts Payable and accrued expenses   $ 934,234     $ 21,217,845     $     $ 22,152,079  
Convertible notes and secured debt     2,450,308       621,293       (621,293 )     2,450,308  
Other Liabilities     893,381                   893,381  
Total Liabilities     4,277,923       21,839,138       (621,293     25,495,768  
Stockholders' Equity     (3,577,557 )     (11,572,618 )     11,572,618       (3,577,557 )
Total Liabilities and Stockholders' Equity   $ 700,366     $ 10,266,520     $ 10,951,325     $ 21,918,211  

 

 

 

 

 2 

 

 

DARKPULSE INC AND SUBSIDIARIES

PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS AND COMPREHENSIVE INCOME

FOR THE SIX MONTHS ENDED JUNE 30, 2021

(Unaudited)

 

    DARKPULSE     Optilan              
    As Reported     Holdco 3 Limited     Pro Forma     Consolidated  
    (6/30/21)     (6/30/21)     Adjustments     Balance  
Revenue   $     $ 11,359,198     $     $ 11,359,198  
Cost of goods sold           12,060,602             12,060,602  
Gross Profit           (701,404 )           (701,404 )
                                 
Operating expenses                                
General and administrative     124,853       727,548             852,401  
Payroll and compensation           3,011,759             3,011,759  
Legal     220,972       188,768             409,740  
Debt transaction expenses     151,950                   151,950  
Depreciation and amortization     25,514       316,486             342,000  
Total Operating expenses     523,289       4,244,561               4,767,850  
Loss from Operations     (523,289 )     (4,945,965 )           (5,469,254 )
                                 
Other Income (Loss)     285,808       16,935,767             17,221,575  
                                 
Income (Loss) before Provision of Income Tax     (237,481 )     11,989,802             11,752,321  
Less Provision of Income Tax                        
                                 
Net Income (Loss)   $ (237,481 )   $ 11,989,802     $     $ 11,752,321  
                                 
Discontinued Operations           (603,821 )           (603,821 )
                                 
Net Income (Loss) available to Stockholders   $ (237,481 )   $ 11,385,981     $     $ 11,148,500  
                                 

Net Loss Per Common Share:

Basic and Diluted

  $ (0.00 )                   $ 0.00  
                                 

Weighted Average Shares Outstanding:

Basic and Diluted

    4,599,529,434                       4,599,529,434  

 

 

 

 3 

 

 

DARKPULSE INC AND SUBSIDIARIES

PRO FORMA CONSOLIDATED BALANCE SHEETS

December 31, 2020

(Unaudited)

 

    DARKPULSE     Optilan              
    As Reported     Holdco 3 Limited     Pro Forma     Consolidated  
    (12/31/20)     (12/31/20)     Adjustments     Balance  
ASSETS                                
                                 
Current Assets                                
Cash   $ 337     $ 1,220,285     $     $ 1,220,622  
Other Current Assets           9,191,079             9,191,079  
Total Current Assets     337       10,411,364             10,411,701  
                                 
Goodwill                 15,620,732       15,620,732  
Intangible assets                 4,033,638       4,033,638  
Patents net     393,990                   393,990  
Other Long Term Assets     91,464       14,413,842       (13,576,178 )     929,128  
Total Assets   $ 485,791     $ 24,825,206     $ 6,078,192     $ 31,389,189  
                                 
LIABILITIES AND STOCKHOLDERS' EQUITY                                
                                 
Current Liabilities                                
Accounts Payable and accrued expenses   $ 1,089,869     $ 30,903,398           $ 31,993,267  
Convertible notes and secured debt     2,107,250       73,133,714     $ (73,133,714 )     2,107,250  
Other Liabilities     1,220,877                   1,220,877  
Total Liabilities     4,417,996       104,037,112       (73,133,714     35,321,394  
Stockholders' Equity     (3,932,205 )     (79,211,906 )     79,211,906       (3,932,205 )
Total Liabilities and Stockholders' Equity   $ 485,791     $ 24,825,206     $ 6,078,192     $ 31,389,189  

 

 

 

 

 4 

 

 

DARKPULSE INC AND SUBSIDIARIES

PRO FORMA CONSOLIDATED STATEMENTS OF OPERATIONS

December 31, 2020

(Unaudited)

 

    DARKPULSE     Optilan              
    As Reported     Holdco 3 Limited     Pro Forma     Consolidated  
    (12/31/20)     (12/31/20)     Adjustments     Balance  
Revenue   $     $ 41,808,652     $     $ 41,808,652  
Cost of goods sold           40,368,926             40,368,926  
Gross Profit           1,439,726             1,439,726  
                                 
Operating expenses                                
General and administrative     149,259       5,882,417             6,031,676  
Payroll and compensation     187       7,419,926             7,420,113  
Legal     50,415       575,118             625,533  
Debt transaction expenses     7,850                   7,850  
Depreciation and amortization     51,028       4,207,241             4,258,269  
Total Operating expenses     258,739       18,084,702               18,343,441  
Loss from Operations     (258,739 )     (16,644,976 )           (16,903,715 )
                                 
Other Income (Loss)     (17,103 )     (5,228,816 )           (5,245,919 )
                                 
Income (Loss) before Provision of Income Tax     (275,842 )     (21,873,792 )           (22,149,634 )
Less Provision of Income Tax           (427,157 )           (427,157 )
                                 
Net Income (Loss)   $ (275,842 )   $ (22,300,949 )   $     $ (22,576,791 )
                                 
Discontinued Operations           640,736             640,736  
                                 
Net Income (Loss) available to Stockholders   $ (275,842 )   $ (21,660,213 )   $     $ (21,936,055 )
                                 

Net Loss Per Common Share:

Basic and Diluted

  $ (0.00 )                   $ (0.01 )
                                 

Weighted Average Shares Outstanding:

Basic and Diluted

    2,323,180,245                     2,323,180,245  

 

 

 

 5 

 

 

Notes to the Pro Forma Consolidated Statements

 

1. Pro Forma adjustments

 

Pro Forma adjustments to the consolidated balance sheets have been made to eliminate the effects of the SPA and to eliminate intercompany loan and cash balances.

 

2. US GAAP adjustments

The un-audited Pro Forma Statements and Audited financial statements of Optilan HoldCo 3 Limited have been prepared in accordance with International Financial Reporting Standards as adopted by the EU (“Adopted IFRSs”). The only material difference between Adopted IFRSs and US GAAP is in the classification of Interest Paid as a Cash flow from Financing in Adopted IFRSs whereas it is an operating cash flow in US GAAP. The impact of this would be to reclassify £383,000 interest paid in 2020 (2019: £422,000) from Cash Flows from financing operations to Net cash from operating activities.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 6